The World Ahead | Science in 2024
Expect a bumper year for weight-loss drugs
The market for drugs such as Wegovy and Mounjaro could be worth $77bn by 2030
By Natasha Loder
FOR decades, weight-loss drugs have been a disappointment, delivering ineffective or even dangerous treatments. The recent arrival of drugs that are both effective and safe is therefore a medical milestone. Some now talk of a long-term future in which obesity might be cured. That is no small claim: obesity is a serious global problem, with 1.1bn people, or roughly 14% of the world’s population, being obese.
This article appeared in the Science and technology section of the print edition of The World Ahead 2024 under the headline “Curing obesity”